Infertility, historically regarded as a personal challenge and costly medical issue, is now prominently featured on the global public-health agenda
Biocon Biologics is moving fast after securing a major settlement with Amgen that clears the way for its Denosumab biosimilars to enter Europe and global markets. Starting December 2, 2025, the company can commercialize both Vevzuo and Evfraxy...
Eli Lilly is rolling out a major Zepbound price cut, lowering the cost of its single-dose vials to make the obesity drug easier for patients to afford. The updated pricing is now live through LillyDirect, the company’s digital health platform...
.png "Glenmark Pharma Scores Zero-483 Outcome in USFDA Inspection")
Glenmark Pharmaceuticals has gained clear momentum in its U.S. pipeline after the USFDA completed a pre?approval inspection of its formulations plant in Chhatrapati Sambhajinagar. The inspection revealed zero 483 observations that reflects...
Biotechnology is poised to significantly enhance Maharashtra's health sciences ecosystem, as the state government plans to establish a cutting-edge Life Sciences Innovation and Incubation Centre designed to expedite research and development within
Granules India Limited unveiled the inauguration of two cutting-edge Centres of Excellence at the Technology Research Park of IIT Hyderabad. These comprise the Ascelis Center of Excellence for Peptide Development
Sun Pharmaceutical Industries introduces its global innovative medication, Ilumya (Tildrakizumab), in India for moderate to severe plaque psoriasis. Ilumya, a new biologic therapy, has been broadly supported by dermatologists in the US
.png "Lupin Secures FDA Approval for Armlupeg Biosimilar Drug")
Lupin has obtained U.S. FDA approval of Armlupeg, a biosimilar of Neulasta. The product is pegfilgrastim 6mg/0.6ml prefilled injection in a single-dose syringe to be used as a subcutaneous injection. The manufacturing will be done in the biotech...
Cloud software leader Veeva Vault CRM is getting a major boost today as Veeva Systems deepens its long-standing partnership with Swiss healthcare powerhouse Roche Pharmaceuticals. The new agreement brings a full global deployment of Veeva’s...
RPG Life Sciences is stepping into India’s growing GLP-1 market — targeting obesity and diabetes — and laying the groundwork for a bold expansion that could reshape its future. The company has outlined an ambition to reach ?2,500 crore turnover...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")